Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016		Mar. 31, 2015
Cash Flows from Operating Activities:
Net loss	$ (487,389)		$ (409,491)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	13,826		13,030
Stock-based compensation expense	48,000		81,229
Changes in operating assets and liabilities:
Prepaid expenses	20,364		22,954
Inventory	(16,883)		0
Accounts payable and accounts payable – related parties	(21,326)		(30,112)
Accrued expenses and accrued expenses – related parties	15,273		57,500
Net Cash Used in Operating Activities	(428,135)		(264,890)
Cash Flows from Investing Activities:
Cost of registering patents	(6,269)		(8,543)
Net Cash Used in Investing Activities	(6,269)		(8,543)
Cash Flows from Financing Activities:
Principal payments on notes payable	(22,889)		(23,291)
Issuance of common stock for cash	0		171,000
Net Cash (Used in) Provided by Financing Activities	(22,889)		147,709
Effect of Foreign Currency Exchange Rates	895		18,231
Net decrease in cash	(456,398)		(107,493)
Cash as of beginning of the period	745,078	[1]	140,496
Cash as of end of the period	288,680		33,003
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	3,318		482
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
Financing of insurance policies	$ 31,500		$ 31,000

[1] The condensed consolidated balance sheet as of December 31, 2015 has been prepared using information from the audited consolidated balance sheet as of that date.